Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 22;10(1):12184.
doi: 10.1038/s41598-020-68848-9.

Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

Collaborators, Affiliations

Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

Yixin Gao et al. Sci Rep. .

Abstract

We employed Mendelian randomization (MR) to evaluate the causal relationship between leukocyte telomere length (LTL) and amyotrophic lateral sclerosis (ALS) with summary statistics from genome-wide association studies (n = ~ 38,000 for LTL and ~ 81,000 for ALS in the European population; n = ~ 23,000 for LTL and ~ 4,100 for ALS in the Asian population). We further evaluated mediation roles of lipids in the pathway from LTL to ALS. The odds ratio per standard deviation decrease of LTL on ALS was 1.10 (95% CI 0.93-1.31, p = 0.274) in the European population and 0.75 (95% CI 0.53-1.07, p = 0.116) in the Asian population. This null association was also detected between LTL and frontotemporal dementia in the European population. However, we found that an indirect effect of LTL on ALS might be mediated by low density lipoprotein (LDL) or total cholesterol (TC) in the European population. These results were robust against extensive sensitivity analyses. Overall, our MR study did not support the direct causal association between LTL and the ALS risk in neither population, but provided suggestive evidence for the mediation role of LDL or TC on the influence of LTL and ALS in the European population.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Relationship between effect sizes on LTL and ALS/FTD for SNPs served as instrumental variables. Results are shown for seven SNPs of ALS (a) and six SNPs of FTD (b) in the European population. Results are also displayed for eight SNPs of ALS in the Asian population (c). In each panel, horizontal/vertical lines represent the 95% confidence intervals.
Figure 2
Figure 2
Statistical power calculation for the causal effect of LTL on ALS estimated with the method proposed in. In the calculation, the total phenotypic variance explained by instrumental variables was 1.26% and the proportion of ALS cases varied from 0.1 to 0.5, the significance level was 0.05, the sample size was 20,000, 37,684, 80,610 or 100,000, and the OR = 1.10 or 1.20.

References

    1. Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat. Rev. Neurol. 2013;9:617–628. - PubMed
    1. Armon C. Smoking is a cause of amyotrophic lateral sclerosis. High low-density lipoprotein cholesterol levels? Unsure. Ann. Neurol. 2019;85:465–469. - PubMed
    1. Bandres-Ciga S, et al. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann. Neurol. 2019;85:470–481. - PMC - PubMed
    1. Zhan Y, Fang F. Smoking and amyotrophic lateral sclerosis: a mendelian randomization study. Ann. Neurol. 2019;85:482–484. - PubMed
    1. Arthur KC, et al. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat. Commun. 2016;7:12408. - PMC - PubMed

Publication types

MeSH terms